882 — Tianjin Development Holdings Share News
0.000.00%
- HK$2.13bn
- HK$2.30bn
- HK$3.20bn
Brief: Tianjin Development Says Qtrly Net Profit Attributable Of Tianjin Lisheng Pharmaceutical Co RMB42 Mln
Brief: Tianjin Development Announces Proposed Final Dividend Of HK5.50 Cents Per Share
Brief: Tianjin Development Sees Increase In Consol Net Profit Attributable For Year By 55% To 65%
Brief: Tianjin Development FY Prelim Net Profit Attributable Rmb121.7 Million
Brief: Tianjin Development Says Zhang Bingjun Resigned As Chairman And Executive Director
Brief: Tianjin Development Says Chen Yanhua Has Resigned As Executive Director
Brief: Tianjin Development Declares Interim Dividend Of Hk3.45 Cents Per Share
Brief: Tianjin Development Says HY Net Profit Attributable Of Tianjin Lisheng Pharmaceutical RMB61.3 Mln
Brief: Tianjin Development Sees Increase Of About 130% In HY Profit Attributable
Brief: Tianjin Development Says FY Net Profit Attributable Of Tianjin Lisheng Pharmaceutical Is RMB8.6 Million
Brief: Tianjin Development Sees Decline In Consolidated Net Profit Attributable For Year
Brief: Tianjin Development Says Tianjin Pharma May Entrust Members Of Group With Manufacturing, Processing Certain Drugs Under Drug Mah System
Brief: Tianjin Development Says Zhang Bingjun Appointed As Chairman And Executive Director
Brief: Tianjin Development Says Unit To Subscribe For Investment Shares Of Segregated Portfolio
Brief: Tianjin Development Holdings Posts HY Revenue HK$1.43 Bln Vs HK$1.86 Bln
Brief: Tianjin Development Says Lisheng Pharmaceutical To Subscribe For Wealth Management Products
Brief: Tianjin Development Sees Decrease In H1 Profit Attributable By About 60% To 70%
Brief: Tianjin Development Announces Disposal Of Entire Stake In Tianjin Heavenly Palace Winery
Brief: Tianjin Development Says Unit To Dispose 78.45% Stake In Tianjin Tianduan